Compare USEG & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | USEG | ICCM |
|---|---|---|
| Founded | 1966 | 2006 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | |
| Sector | Energy | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 46.5M | 41.4M |
| IPO Year | 1995 | 2013 |
| Metric | USEG | ICCM |
|---|---|---|
| Price | $0.81 | $0.35 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $3.50 | $2.50 |
| AVG Volume (30 Days) | ★ 3.0M | 726.5K |
| Earning Date | 05-11-2026 | 05-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 55.21 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $32,379,000.00 | N/A |
| Revenue This Year | $114,854.51 | $139.51 |
| Revenue Next Year | N/A | $75.66 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.66 | $0.28 |
| 52 Week High | $2.75 | $1.40 |
| Indicator | USEG | ICCM |
|---|---|---|
| Relative Strength Index (RSI) | 45.31 | 37.69 |
| Support Level | $0.66 | $0.28 |
| Resistance Level | $1.08 | $0.74 |
| Average True Range (ATR) | 0.07 | 0.03 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 47.19 | 76.90 |
US Energy Corp is an independent energy company. It is focused on the acquisition and development of oil and natural gas-producing properties in the continental United States. It has business properties and operations in the Rockies region (Montana, Wyoming, and North Dakota), the Mid-Continent (Oklahoma, Kansas, and North and East Texas), and the West Texas, South Texas, and Gulf Coast regions. The company generates revenue from its interest in the sales of oil and natural gas production. The group operates in the exploration and production segment of the oil and gas industry, onshore in the United States.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.